At Alfa we value sustainable and long-term partnerships
We are open to exploring strategic partnerships with a focus on licensing, co-development, co-commercialization.
Our current therapeutic areas of interest are:
- Cardiovascular system
- Pain Management and
European and growth market opportunities
With respect to the European markets, we are looking to market products which leverage our existing portfolio and commercial platforms. Whilst we are prioritizing products in the pre-registration and commercial stages, we are open to assisting new partners in obtaining late-stage drug approval in Europe and assisting in building a value-proposition for its pricing, market access and reimbursement. Region-wide deals are our bread and butter. However, we are also well versed with country-by-country distribution, co-marketing or co-promotion arrangements. We offer broad commercial coverage, and excellent relationships with members of our pharmaceutical network.
Alfa’s growth market region includes the Middle-East, Africa, LATAM and Asian markets. For these markets and others, we are looking to expand our range of products for our business partners to market and distribute.
Please feel free to send us your opportunities through the email below. We are committed to provide timely feedback.